The materials for DUPIXENT contained in this virtual exhibition are approved for use only in the United States of America. Prescribing information may vary depending on local approval in each country. Therefore, before prescribing any product, always refer to local materials such as the full Prescribing Information and/or the Summary of Product Characteristics (SmPC).

SKIP

EXPLORE THE FIRST AND ONLY DUAL INHIBITOR OF IL-4 AND IL-13 SIGNALING1

The mechanism of dupilumab action in asthma has not been definitively established.

 
PATIENT CONVERSATION GUIDE

Use this guide during discussions
with your appropriate patients

 
VIEW MOA

Explore the science behind the mechanism of action of DUPIXENT

 
HEAR FROM THE EXPERTS

Dr Tan: Discussing the MOA of DUPIXENT


Dr Tan: Discussing an OCS-Dependent Asthma Patient Case


Dr Tan: Discussing Patient Demographics


Dr Sher: Discussing the Significant Efficacy
of DUPIXENT


Dr Sher: Discussing the Impact of Dual Inhibition


Dr Sher: Discussing the Impact of Type 2 Inflammation

 
EXPLORE ASTHMA DATA

Long-Term Data: Download this asset to see the data up to ~3 years


OCS-Dependent Patient Resource: View the data and an appropriate patient type for DUPIXENT


Severe Asthma Patient With Elevated Resource: See a patient type appropriate for DUPIXENT and explore the data


Allergic Asthma Patient With Elevated Resource: Explore the data and an appropriate patient type for DUPIXENT


Child With Uncontrolled Eosinophilic Asthma Resource: Examine the pediatric data and appropriate patient type for DUPIXENT

 
DUPIXENT MyWay®

Enrollment Video: Information to help your appropriate patients with the enrollment process


Delivery Video: See how your appropriate patients can access DUPIXENT


Allergist Enrollment Form: English


Allergist Enrollment Form: Spanish


ENT Specialist/Pulmonologist Enrollment Form: English


ENT Specialist/Pulmonologist Enrollment Form: Spanish

 
VIEW THE PEDIATRIC
INDICATION

Discover this patient population indicated for DUPIXENT

 
PRE-FILLED PEN AND SYRINGE

Explore the administration options available with DUPIXENT


Dosing Card

APPROVED FOR 3 INDICATIONS


EXPLORE ADDITIONAL
INDICATIONS
SWIPE TO EXPLORE

EOS, eosinophils; OCS, oral corticosteroid.

Reference:

  1. DUPIXENT Prescribing Information.